1-4 of 4
Morie Abraham Gertz, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cardiac Biomarkers Predict for Ability To Tolerate and Complete Therapy with Lenalidomide ± Dexamathosone in AL Amyloidosis.

Angela Dispenzieri, MD, Martha Lacy, M.D., Steven Zeldenrust, M.D., Ph.D., Suzanne R. Hayman, M.D., Shaji Kumar, M.D., Susan M. Geyer, Ph.D., John A. Lust, M.D., Ph.D., Jacob B. Allred, M.S., Thomas E. Witzig, M.D, S. Vincent Rajkumar, M.D., Philip R. Greipp, M.D., Stephen J. Russell, M.D., Ph.D., Brian Kabat, Morie Abraham Gertz, M.D.
Journal: Blood
Blood (2006) 108 (11): 130.
https://doi.org/10.1182/blood.V108.11.130.130
Published: 2006
Journal Articles

Early Immunoglobulin Free Light Chain (FLC) Response Post Autologous Peripheral Blood Stem Cell Transplant Predicts for Hematologic Complete Response in Patients with Multiple Myeloma.

Angela Dispenzieri, MD, S. Vincent Rajkumar, M.D., Matthew F. Plevak, Jerry A. Katzmann, Robert A. Kyle, M.D., Dirk Larson, M.S., Martha Q. Lacy, M.D., Raynell Clark, Roberta DeGoey, Suzanne R. Hayman, M.D., Shaji K. Kumar, M.D., Morie Abraham Gertz, M.D.
Journal: Blood
Blood (2006) 108 (11): 3097.
https://doi.org/10.1182/blood.V108.11.3097.3097
Published: 2006
Journal Articles

Definition of Organ Involvement and Treatment Response in Primary Systemic Amyloidosis (AL): A Consensus Opinion from the 10th International Symposium on Amyloid and Amyloidosis.

Morie Abraham Gertz, M.D., Raymond Comenzo, M.D., Rodney H. Falk, M.D., Jean-Paul Fermand, M.D., Bouke P. Hazenberg, M.D., Philip N. Hawkins, M.D., Giampaolo Merlini, M.D., Philippe Moreau, M.D., Pierre Ronco, M.D., Vaishali Sanchorawala, M.D., Orhan Sezer, M.D., Alan Solomon, M.D., Giles Grateau, M.D.
Journal: Blood
Blood (2004) 104 (11): 754.
https://doi.org/10.1182/blood.V104.11.754.754
Published: 2004
Journal Articles

Deletion 13 by FISH Provides Prognostic Information on Overall Survival and Time to Progression Independent of Serum Beta 2 Microglobulin and Bone Marrow Plasma Cell Labeling Index in Myeloma Patients Undergoing Stem Cell Transplantation.

Morie Abraham Gertz, M.D., Martha Q. Lacy, M.D., Angela Dispenzieri, M.D., Philip R. Greipp, M.D., Mark R. Litzow, M.D., Kim J. Henderson, BA, Scott VanWier, BA, Greg Ahmann, BA, Rafael Fonseca, M.D.
Journal: Blood
Blood (2004) 104 (11): 4852.
https://doi.org/10.1182/blood.V104.11.4852.4852
Published: 2004